Terms: = Colorectal cancer AND PALB2, ENSG00000083093, 79728 AND Diagnosis
9 results:
1. Case-case analysis addressing ascertainment bias for multigene panel testing implicates BRCA1 and palb2 in endometrial cancer.
Johnatty SE; Pesaran T; Dolinsky J; Yussuf A; LaDuca H; James PA; O'Mara TA; Spurdle AB
Hum Mutat; 2021 Oct; 42(10):1265-1278. PubMed ID: 34245638
[TBL] [Abstract] [Full Text] [Related]
2. Predicted Chemotherapy Benefit for Breast cancer Patients With Germline Pathogenic Variants in cancer Susceptibility Genes.
Kurian AW; Ward KC; Abrahamse P; Hamilton AS; Katz SJ
JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33426465
[TBL] [Abstract] [Full Text] [Related]
3. Report of a germline double heterozygote in MSH2 and palb2.
Agiannitopoulos K; Papadopoulou E; Tsaousis GN; Pepe G; Kampouri S; Patsea E; Lypas G; Nasioulas G
Mol Genet Genomic Med; 2020 Oct; 8(10):e1242. PubMed ID: 32853479
[TBL] [Abstract] [Full Text] [Related]
4. cancer Susceptibility Gene Mutations in Individuals With colorectal cancer.
Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
[TBL] [Abstract] [Full Text] [Related]
5. Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.
Susswein LR; Marshall ML; Nusbaum R; Vogel Postula KJ; Weissman SM; Yackowski L; Vaccari EM; Bissonnette J; Booker JK; Cremona ML; Gibellini F; Murphy PD; Pineda-Alvarez DE; Pollevick GD; Xu Z; Richard G; Bale S; Klein RT; Hruska KS; Chung WK
Genet Med; 2016 Aug; 18(8):823-32. PubMed ID: 26681312
[TBL] [Abstract] [Full Text] [Related]
6. Identification of germline genetic mutations in patients with pancreatic cancer.
Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
[TBL] [Abstract] [Full Text] [Related]
7. Hereditary ovarian cancer: not only BRCA 1 and 2 genes.
Toss A; Tomasello C; Razzaboni E; Contu G; Grandi G; Cagnacci A; Schilder RJ; Cortesi L
Biomed Res Int; 2015; 2015():341723. PubMed ID: 26075229
[TBL] [Abstract] [Full Text] [Related]
8. Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer.
Grant RC; Selander I; Connor AA; Selvarajah S; Borgida A; Briollais L; Petersen GM; Lerner-Ellis J; Holter S; Gallinger S
Gastroenterology; 2015 Mar; 148(3):556-64. PubMed ID: 25479140
[TBL] [Abstract] [Full Text] [Related]
9. Genetic susceptibility to pancreatic cancer.
Klein AP
Mol Carcinog; 2012 Jan; 51(1):14-24. PubMed ID: 22162228
[TBL] [Abstract] [Full Text] [Related]
